Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: ...

DB Biomedical Ltd, a Nigerian-founded health technology company, has launched DB GlucoTrack, a web-based application designed ...

K Street is still digesting the 90-day pause on Trump’s so-called reciprocal tariffs to chart the best path forward for clients over the next three months.

A new agreement with OneTwo Analytics AB will allow Glucotrack to leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its continu ...

Glucotrack, Inc., a medical device company with a market capitalization of $1.78 million, has received a notification from the Nasdaq Stock Market indicating a potential delisting of its securities ...

Glucotrack, Inc., a medical device company with a market capitalization of $1.78 million, has received a notification from the Nasdaq Stock Market indicating a potential delisting of its ...